Botulinum toxin therapy: past, present and future developments.

Area of Science:

• Neurology
• Pharmacology
• Biotechnology

Background:

• Botulinum toxin (BT) is increasingly used across medical specialties.
• Ongoing advancements are refining BT applications and drug formulations.

Purpose of the Study:

• To review the current state and future directions of botulinum toxin therapy.
• To identify key developments in drug analogues, delivery methods, and therapeutic indications.

Main Methods:

• Review of current literature and ongoing research in botulinum toxin therapy.
• Analysis of emerging drug development trends and regulatory considerations.

Main Results:

• Improvements in BT treatment algorithms include short-interval and high-dose therapies, with ultrasound guidance for specific cases.
• New indications such as depression and inflammatory conditions are under investigation.
• Drug development focuses on onabotulinumtoxinA analogues, liquid preparations, and modified action durations.

Conclusions:

• Botulinum toxin type A remains the preferred agent, with potential for protein modifications and recombinant production.
• Expanding patient access and reforming high-cost business models are critical challenges for future BT therapy.
• Further refinement of treatment algorithms and exploration of novel indications are expected.